1 / 21

Insulin Titration Trial

Insulin Titration Trial. Will Hsu MD. Aldo Rossini MD. Sue Ghiloni RN, CDE. Paige Ricci. Insulin Titration Trial - Design. Type II Diabetics >18 yo , HbA1C 9-14%, Starting insulin 3 month, randomized, controlled trial Control: standard of care at Joslin

cecily
Download Presentation

Insulin Titration Trial

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Insulin Titration Trial Will Hsu MD Aldo Rossini MD Sue Ghiloni RN, CDE Paige Ricci

  2. Insulin Titration Trial - Design • Type II Diabetics • >18 yo, HbA1C 9-14%, Starting insulin • 3 month, randomized, controlled trial • Control: standard of care at Joslin • Self-titration + diabetes educator • Intervention: apprenticeship at Joslin • Tablet with CollaboRhythm + 303 Protocol + coach • Primary Outcome: Δ HbA1C

  3. Insulin Titration Trial - Technology

  4. Insulin Titration Trial - Technology

  5. Insulin Titration Trial - Technology

  6. Insulin Titration Trial - Technology

  7. Insulin Titration Trial - Technology

  8. Insulin Titration Trial - Technology

  9. Insulin Titration Trial - Technology

  10. Insulin Titration Trial - Technology

  11. Insulin Titration Trial - Technology

  12. Insulin Titration Trial - Technology

  13. Insulin Titration Trial - Technology

  14. Insulin Titration Trial - Technology

  15. Insulin Titration Trial - Technology

  16. Insulin Titration Trial - Technology

  17. Insulin Titration Trial - Technology

  18. Insulin Titration Trial - Technology

  19. Insulin Titration Trial - Technology

  20. p = 0.195 • ▼2% HbA1Cvs standard ~ ▼40% complications • ~ $4 K savings / year / patient, $120 K lifetime • ~ $15 B savings / year for US • ▼0.6% HbA1C vs Joslin ~ ▼12% complications • Spent extra $315 in clinician time per patient • $14,000 in lifetime savings per patient • ▼1% HbAIC~▼20% complications • Heart attack, stroke, kidney failure, vision loss… Menighini (2007) Avg HbA1C = 8.5% Sample = 5604 Duration = 6 months Yki-Jarvinen (2007) Avg HbA1C = 8.9% Sample = 121 Duration = 6 months Moore (2013) Avg HbA1C = 10.8% Sample = 25 Duration = 3 months Davis (2013) Real-world comparative outcomes of US type 2 diabetes patients initiating analog basal insulin therapy. Curr Med Res Op Caro (2002) Lifetime Costs of Complications Resulting from Type 2 Diabetes in the US. Diabetes Care American Association of Clinical Endocrinologists (2006) State of Diabetes Complications in America. CDC (2011) National Diabetes Fact Sheet. Stratton (2000) Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35). BMJ

  21. Insulin Titration Trial - Experience p = 0.015 p = 0.005 Pre Post Pre Post Bradley (1994) The Diabetes Treatment Satisfaction Questionnaire: DTSQ

More Related